Company profile

Biorelate company profile

Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2014-01-01

Headquarters

Headquarters
Oldham, England, United Kingdom
Postal code
OL1 1TE
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$8.8M
Last funding
Series A / $7.8M / 2022-11-29
Last equity funding
Series A / $7.8M
Investors
8
Lead investors
3
Founders
1
Articles
8

Founders and investors

Founders

Daniel Jamieson

Lead investors

Maven Capital PartnersNPIF Maven Equity FinanceYFM Equity Partners

Investors

Catapult VenturesMaven Capital PartnersNorthern Powerhouse Investment FundTriple Point VenturesYFM Equity Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.